NASDAQ: BRNS - Barinthus Biotherapeutics plc

Yield per half year: -26.06%
Dividend yield: 0.00%

Barinthus Biotherapeutics plc

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 0 0% 1.94 -100%
P/S 167.83 0 0%
P/BV 0.7226 0 0%
P/FCF 0 0 0%
Ev/Ebitda -0.0845 0 0%
Ev/S 7.46 0 0%
Ev/FCF -0.1066 0 0%
E/P 0 0 0%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-8826.77 0 0% -4918.1 +79.48%
ROE -39.42 0 0%
ROA -34.33 0 0%
ROIC 0 0 0%
ROS -9145.52 0 0%
ROCE -40.92 0 0%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.1826 0 0% 0.1286 -242.02%
Nеt Debt/Ebitda 1.82 0 0%
Debt/Ratio 0.0605 0 0%
Debt/Equity 0 0 0%
Debt/Net Income -0.1762 0 0%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0 0% 0 0%
Number of years of dividend growth 0 0 0%
DSI 0 0 0%
Average dividend growth 0 0 0%
Average percentage for 5 years 0 0 0%
Average percentage for payments 0 0 0%
Difference from average difference in sector 0

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-88.38 0 0%
Growth impulse Ebitda in 5 years 179.78 0 0%
Growth impulse Net Income in 5 years 252.63 0 0%
Growth impulse FCF in 5 years 198.08 0 0%
Growth impulse EPS in 5 years 212.67 0 0%
IP Score
4.51/10

Similar companies

SenesTech, Inc.

ZeroFox Holdings, Inc.

Apollomics, Inc.

Complete Solaria, Inc.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription